MAG
ELGX

Millrace Asset Group’s Endologix Inc ELGX Stock Holding History

Millrace Asset Group’s Portfolio ELGX Stock Details ELGX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2018
Q1 		– Sell
-12,500
Closed -$669K – 79
2017
Q4 		$669K Buy
+12,500
New +$660K 0.64% 57

Other funds holding ELGX

ACH
ArrowMark Colorado Holdings Denver, Colorado $3.76B AUM 21.77% 1-Year Est. Return
CCM
Camber Capital Management Boston, Massachusetts $1.07B AUM 8.19% 1-Year Est. Return
BCM
Brown Capital Management Baltimore, Maryland $704M AUM 6.25% 1-Year Est. Return
PHS
PFM Health Sciences San Francisco, California $1.1B AUM 57.92% 1-Year Est. Return
RG
Redmile Group San Francisco, California $1.51B AUM 164.17% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
EWM
Essex Woodlands Management The Woodlands, Texas $251M AUM 13.72% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
NMC
NEA Management Company Timonium, Maryland $1.76B AUM 223.33% 1-Year Est. Return

Millrace Asset Group's ELGX Position: Q1 2018 in Review

Millrace Asset Group sold out of Endologix Inc (ELGX) in Q1 2018, closing a stake of 12,500 shares — an estimated $669K sold.

Millrace Asset Group first reported a position in ELGX in Q4 2017 and held it in 1 quarter. The position peaked at $669K in Q4 2017. 97 funds tracked by Wall St. Rank hold ELGX as of Q1 2018.

  • Millrace Asset Group reported no remaining Endologix Inc position as of Q1 2018 after selling out during the quarter.
  • Millrace Asset Group sold 12,500 Endologix Inc shares in Q1 2018, an estimated $669K.
  • Millrace Asset Group first reported a position in Endologix Inc in Q4 2017 and held it in 1 quarter.
  • Millrace Asset Group's Endologix Inc position peaked at $669K in Q4 2017.
  • 97 funds tracked by Wall St. Rank held Endologix Inc as of Q1 2018.

Based on Millrace Asset Group's 13F filing for Q1 2018, filed 15 May 2018.